State of Wyoming’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-29
Closed -$632 1634
2023
Q2
$632 Buy
29
+9
+45% +$239 ﹤0.01% 1524
2023
Q1
$568 Sell
20
-1
-5% -$30 ﹤0.01% 1547
2022
Q4
$475 Buy
21
+15
+250% +$342 ﹤0.01% 1526
2022
Q3
$0 Buy
+6
New +$194 ﹤0.01% 1561
2022
Q2
Sell
-1
Closed 1887
2022
Q1
$0 Hold
1
﹤0.01% 1804
2021
Q4
$0 Hold
1
﹤0.01% 1870
2021
Q3
$0 Sell
1
-1
-50% -$222 ﹤0.01% 1225
2021
Q2
$1K Buy
2
+1
+100% +$296 ﹤0.01% 1126
2021
Q1
$0 Buy
+1
New +$304 ﹤0.01% 515

Other funds holding BNR

State of Wyoming's BNR Position: Q3 2023 in Review

State of Wyoming sold out of Burning Rock Biotech (BNR) in Q3 2023, closing a stake of 29 shares — an estimated $632 sold.

State of Wyoming first reported a position in BNR in Q1 2021 and held it in 9 quarters. The position peaked at $1K in Q2 2021. 28 funds tracked by Wall St. Rank hold BNR as of Q3 2023.

  • State of Wyoming reported no remaining Burning Rock Biotech position as of Q3 2023 after selling out during the quarter.
  • State of Wyoming sold 29 Burning Rock Biotech shares in Q3 2023, an estimated $632.
  • State of Wyoming first reported a position in Burning Rock Biotech in Q1 2021 and held it in 9 quarters.
  • State of Wyoming's Burning Rock Biotech position peaked at $1K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2023.

Based on State of Wyoming's 13F filing for Q3 2023, filed 14 Nov 2023.